Concepedia

Julia Hambach

JH

Statistics

Publications

9

Citations

272

H-Index

9

Active since

2018

Affiliations

University Medical Center Hamburg-Eppendorf(Current)

Universität Hamburg

Julia Hambach is an author at University Medical Center Hamburg-Eppendorf specializing in immunology, cancer immunotherapy, and oncology.

ORCID

Publications per year

2018–2024

9

Publications

9

Targeting CD38-Expressing Multiple Myeloma and Burkitt Lymphoma Cells In Vitro with Nanobody-Based Chimeric Antigen Receptors (Nb-CARs)

Julia Hambach, Kristoffer Riecken, Sophia Cichutek et al. · Cells · 2020 · 64 citations · Full text

, , +17

CD38-Specific Biparatopic Heavy Chain Antibodies Display Potent Complement-Dependent Cytotoxicity Against Multiple Myeloma Cells

Kerstin Schütze, Katharina Petry, Julia Hambach et al. · Frontiers in Immunology · 2018 · 50 citations · Full text

, , +17

An antigen-specific chimeric autoantibody receptor (CAAR) NK cell strategy for the elimination of anti-PLA2R1 and anti-THSD7A antibody-secreting cells

Larissa Seifert, Kristoffer Riecken, Gunther Zahner et al. · Kidney International · 2024 · 45 citations · Full text

, , +17

Nanobody-based CD38-specific heavy chain antibodies induce killing of multiple myeloma and other hematological malignancies

Levin Schriewer, Kerstin Schütze, Katharina Petry et al. · Theranostics · 2020 · 25 citations · Full text

, , +17

Half-Life Extended Nanobody-Based CD38-Specific Bispecific Killercell Engagers Induce Killing of Multiple Myeloma Cells

Julia Hambach, William Fumey, Tobias Stähler et al. · Frontiers in Immunology · 2022 · 24 citations · Full text

, , +17

1–5 of 9